Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 23315161

Anagrelide compared with hydroxyurea in WHO-classified essential thrombocythemia: the ANAHYDRET Study, a randomized controlled trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Blood
Publication date
2013 Mar 7
First author
Gisslinger H

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Gisslinger H
      type
      Author
    2. name
      Gotic M
      type
      Author
    3. name
      Holowiecki J
      type
      Author
    4. name
      Penka M
      type
      Author
    5. name
      Thiele J
      type
      Author
    6. name
      Kvasnicka HM
      type
      Author
    7. name
      Kralovics R
      type
      Author
    8. name
      Petrides PE
      type
      Author
    9. name
      ANAHYDRET Study Group
      type
      CollectiveName
    Complete bibliographic record and source provenance
    authors
    1. name
      Gisslinger H
      type
      Author
    2. name
      Gotic M
      type
      Author
    3. name
      Holowiecki J
      type
      Author
    4. name
      Penka M
      type
      Author
    5. name
      Thiele J
      type
      Author
    6. name
      Kvasnicka HM
      type
      Author
    7. name
      Kralovics R
      type
      Author
    8. name
      Petrides PE
      type
      Author
    9. name
      ANAHYDRET Study Group
      type
      CollectiveName
    bibliography ids
    1. nci-bib-d664a77f181bc44ab51e0746
    book metadata
    content sha256
    8cf0bf27b52c62d623dfe9338fea0e4037b13081fdd7851e4a54afdecfd5f81f
    document type
    citation
    dois
    1. 10.1182/blood-2012-07-443770
    electronic publication date
    display
    2013 Jan 11
    precision
    day
    year
    2013
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:23315161
    immutable id
    pubmed:23315161@8cf0bf27b52c62d623dfe9338fea0e4037b13081fdd7851e4a54afdecfd5f81f
    journal
    abbreviation
    Blood
    issn electronic
    1528-0020
    issn print
    0006-4971
    issue
    10
    name
    Blood
    nlm unique id
    7603509
    pages
    1720-8
    volume
    121
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      23315161
      provenance
      batch id
      99e85dbb34a1a3011c9a
      provider
      NCBI PubMed ESummary
      record sha256
      1bf047cd4875365841c7c3e0b376c775aea786fba06e5d0f0d3a157a4c45ee1c
      response sha256
      1f4a46dcee9da36f8f58fe356dce3f44a1b3004f404e9fb0184f4e08aed4acf2
      retrieved at
      2026-09-09T23:46:52.860383+00:00
      publication date
      display
      2013 Mar 7
      precision
      day
      year
      2013
      publication types
      1. Clinical Trial, Phase III
      2. Comparative Study
      3. Journal Article
      4. Multicenter Study
      5. Randomized Controlled Trial
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/23315161/
      title
      Anagrelide compared with hydroxyurea in WHO-classified essential thrombocythemia: the ANAHYDRET Study, a randomized controlled trial.

      Preserved source evidence · Not medical advice